In high-grade serous ovarian cancer, Sheets JN demonstrated that SUSD2 impedes migration, EMT and mesothelial clearance of cancer cells, consistent with prolonged survival of patients with SUSD2-positive tumors 11. This evidence concerns the gene SUSD2 and ovarian serous adenocarcinoma.